C World Wide Group Holding A Esperion Therapeutics, Inc. Transaction History

C World Wide Group Holding A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$40.11 - $53.57 $195,496 - $261,100	-4,874 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$36.99 - $59.11 $4,623 - $7,388	-125 Reduced 2.5%	4,874 $224,000
Q3 2018 Nov 05, 2018	BUY	$40.74 - $51.41 $28,314 - $35,729	695 Added 16.15%	4,999 $222,000
Q1 2018 May 03, 2018	SELL	$65.94 - $80.76 $8,506 - $10,418	-129 Reduced 2.91%	4,304 $311,000
Q4 2017 Feb 07, 2018	SELL	$43.47 - $67.43 $25,169 - $39,041	-579 Reduced 11.55%	4,433 $292,000
Q3 2017 Nov 06, 2017	BUY	$43.8 - $52.77 $219,525 - $264,483	5,012	5,012 $251,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.